Seeking Alpha
 

Mesoblast Ltd. ADR (MBLTY)

- OTCPK - Current
MBLTY vs. ETF Alternatives
Company Description
Mesoblast is developing a series of high margin, off-the-shelf adult stem cell products that are obtained from a single donor, commercially expanded and frozen, and subsequently used in potentially thousands of unrelated, or allogeneic, recipients at the time and place of need.
Sector: Healthcare
Industry: Biotechnology
Country: Australia